Latest News

Biopharmaceutical company DBV Technologies has announced positive results from its Viaskin® Peanut trial into reducing the risk of allergic reaction in children aged 4 to 11. Viaskin is a patch applied directly to the surface of the skin and contains

The Anaphylaxis Campaign has received and has been asked to share the following update from Sacla regarding its recent pesto recall. Update from Sacla: Customer health and safety is always our number one priority. In December, when we became aware that cashew

The Coroner has ended the inquest into the death of Shante Turay-Thomas and has delivered her narrative determination and the Prevention of Future Deaths report. The Anaphylaxis Campaign would like to extend our deepest condolences to the family of Shante,

The Anaphylaxis Campaign is saddened to learn of the death of Ken Matthews, 84,  who died at Wrexham Maelor Hospital on 2 June 2019. Consultant pathologist Dr Huyen Abdel Salam told the inquest that Mr Matthews died of an allergic

The Artichoke, Croxley Green, has been fined £23,000 after being prosecuted by Hertfordshire Trading Standards when one of its customers became seriously ill. Hertfordshire County Council said KOB (The Artichoke) Ltd pleaded guilty to offences under the Food Safety Act

New findings from the London-based EAT Study have shown that giving certain allergenic foods to specific groups of babies at high risk of developing allergies, from as young as three months could reduce the likelihood of them developing an allergy

New findings from the London-based EAT Study have shown that giving certain allergenic foods to specific groups of babies at high risk of developing allergies, from as young as three months could reduce the likelihood of them developing an allergy to those foods. 

Latest figures reveal that hospital admissions for anaphylactic shock for all causes has risen by around 70% in the past five years, from 2013-2014 to 2018-2019, for under 18’s, as shown in the graph below. Hospital admissions for anaphylactic shock

The Anaphylaxis Campaign is saddened to learn of the death of Dennis Walsh, a 70-year-old who died due to a severe anaphylactic reaction to the contrast dye used during a CT scan on 8 August 2019 at Royal Blackburn Hospital.